ANITA DESWAL to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications ANITA DESWAL has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
1.952
-
ACP Journal Club. Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality. Ann Intern Med. 2016 Apr 19; 164(8):JC41.
Score: 0.432
-
Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction. Evid Based Med. 2013 Dec; 18(6):226-7.
Score: 0.350
-
Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin. 2008 Feb; 26(1):1-14, v.
Score: 0.244
-
Anti-angiotensin therapy: new perspectives. Cardiol Clin. 2007 Nov; 25(4):573-80; vi-vii.
Score: 0.240
-
Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy. Heart Fail Clin. 2005 Apr; 1(1):25-37.
Score: 0.197
-
Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose. N Engl J Med. 2003 Nov 13; 349(20):1963-5.
Score: 0.182
-
Higher risk, high yield: renin-angiotensin system blockade after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2020 02; 73(2):104-106.
Score: 0.137
-
Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol. 2008 May; 23(3):233-40.
Score: 0.062
-
Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J. 2006 Aug; 152(2):348-54.
Score: 0.055
-
Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
Score: 0.027
-
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
Score: 0.017
-
Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit. 2001; 1(4):114-21.
Score: 0.009